SynthesisSystematic reviews2020
Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis.
Synthesis in Systematic reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Association Between Time to Treatment and Disease-free Survival of Patients With High-risk Cutaneous Squamous Cell Carcinoma in the Head and Neck Region.
The Needs and Preferences of Patients With High-risk Cutaneous Squamous Cell Carcinomas in the Head Neck Region: a Qualitative Approach
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Definition and conceptualization of the patient-centered care pathway, a proposed integrative framework for consensus: a Concept analysis and systematic review.BMC health services research · 2022Pooled it
- Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS network.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- International multi-stakeholder collaboration to support implementation of cancer care efficiency metrics: a qualitative study to develop the All.Can Action Guide.Health research policy and systems · 2026Article
- Obesity Treatment Pathways and Implementation in Health Systems.Obesity science & practice · 2026Review
- The Association Between Alignment to the Breast Cancer Optimal Care Pathways and Patient Survival in Victoria, Australia, 2012-2019: A Retrospective Population-Based Cohort Study.The Medical journal of Australia · 2026Article
- Treatment pathways of lung cancer patients in the Czech Republic: insights from administrative claims data.BMJ open respiratory research · 2026Article
- AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma.Journal of managed care & specialty pharmacy · 2025Article
- Development and provider assessment of a new oncology network with care pathways for gastrointestinal cancer patients: the collaborative approach.BMC cancer · 2025Article
- Healthy days at home and prognosis of older adults with cancer and non-cancer serious life-limiting illnesses.BMC geriatrics · 2025Article
- Optimising prostate cancer pathways: Improving post-biopsy waiting times in a tertiary centre.BJUI compass · 2025Article
- "I Became the Messenger Between the Hospitals": A Study on the Journeys of People With Cancer Using the Critical Incident Technique.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Visual Modeling Languages in Patient Pathways: Scoping Review.Interactive journal of medical research · 2024Article
- Evolving oncology care management trends in the United States: A survey among health care decision makers.Journal of managed care & specialty pharmacy · 2024Article
- Improving routine use of clinical pathway decision support through integration of an EHR with a clinical library resource designed to provide evidence-based guidance within oncology workflows.BMC health services research · 2024Article
- Identification of an oncological clinical pathway through questionnaires to health professionals.BMC health services research · 2023Article
- Role of digital health in coordinating patient care in a hub-and-spoke hierarchy of cancer care facilities: a scoping review.Ecancermedicalscience · 2023Article
- The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings.BMC health services research · 2022Article
- Reorganizing the Multidisciplinary Team Meetings in a Tertiary Centre for Gastro-Intestinal Oncology Adds Value to the Internal and Regional Care Pathways. A Mixed Method Evaluation.International journal of integrated care · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPathways are frequently used to improve care for cancer patients. However, there is little evidence about the effects of pathways used in oncological care. Therefore, we performed a systematic review and meta-analysis aiming to identify and synthesize existing literature on the effects of pathways in oncological care.
methodsAll patients diagnosed with cancer in primary and secondary/tertiary care whose treatment can be characterized as the strategy "care pathways" are included in this review. A systematic search in seven databases was conducted to gather evidence. Studies were screened by two independent reviewers. Study outcomes regarding patients, professionals, and system level were extracted from each study.
resultsOut of 13,847 search results, we selected 158 articles eligible for full text assessment. One hundred fifty studies were excluded and the remaining eight studies represented 4786 patients. Most studies were conducted in secondary/tertiary care. Length of stay (LOS) was the most common used indicator, and was reported in five studies. Meta-analysis based on subgroups showed an overall shorter LOS regarding gastric cancer (weighted mean difference (WMD)): - 2.75, CI: - 4.67 to - 0.83) and gynecological cancer (WMD: - 1.58, CI: - 2.10 to - 1.05). Costs were reported in six studies and most studies reported lower costs for pathway groups.
conclusionsDespite the differences between the included studies, we were able to present an evidence base for cancer care pathways performed in secondary/tertiary care regarding the positive effects of LOS in favor of cancer care pathways. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017057592.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.